✨
AI Summary
- BlueRock Therapeutics explores dopamine-restoring cell therapy for Parkinson's.
- Discussing bemdaneprocel's mechanism and limitations of current PD treatments.
- Cell therapies offer a new approach to long-term Parkinson's symptom management.
Guests on This Episode
AR
Amit Rahkit
1 podcast appearance